An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients
Stopped Study was terminated due to funding constraints
Conditions
- Lung Transplant Rejection
Interventions
- DRUG: Tacrolimus Inhalation Powder
- DEVICE: Plastiape RS00 Dry Powder inhaler device
Sponsor
TFF Pharmaceuticals, Inc.
Collaborators